Home » Topics » Regulatory » Patents

Patents
RSS

Novel agents for treating endocrine-related disorders disclosed in recent patent literature

May 30, 2006

Recent patents describe new analgesic agents

May 30, 2006

New treatment options for inflammatory disorders disclosed

May 29, 2006

Recent patents describe novel agents for anxiety, depression, psychosis, etc.

May 29, 2006

Novel therapeutic agents for respiratory disorders disclosed in recent patent literature

May 29, 2006

Novel agents for gastrointestinal disorders disclosed in recent patent literature

May 26, 2006

Agents for metabolic disorders disclosed

May 26, 2006

Novel therapeutic agents for thrombosis and related disorders reported in recent patents

May 26, 2006

Recent Kotobuki patent describes new agents for hyperphosphatemia

May 25, 2006

Chemokine CXCR4 antagonists reported by Merck & Co.

May 25, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...